Transcranial Direct Current Stimulation (tDCS) to Reduce Pain in Patients With Chemotherapy Induced Peripheral Neuropathy: A Pilot Study
试验速览
- 阶段
- 早期 1 期
- 状态
- 撤回
- 试验地点
- 2
- 主要终点
- Change in chemotherapy induced peripheral neuropathy pain score
研究概览
简要总结
This early phase I trial studies how well transcranial direct current stimulation works in reducing pain in cancer patients with chemotherapy induced peripheral neuropathy. Transcranial direct current stimulation is used for patients with brain injuries such as strokes as well as for mental health issues such as depression and may help to control pain in cancer patients with chemotherapy induced peripheral neuropathy.
详细描述
PRIMARY OBJECTIVES:
I. To evaluate the efficacy of transcranial direct current stimulation (tDCS) in reducing chemotherapy induced painful peripheral neuropathy (CIPPN).
Ia. Evaluate the change in pain scores Ib. Assess for changes in other symptoms (i.e insomnia, feeling of well-being, depression and anxiety).
SECONDARY OBJECTIVES:
I. To evaluate the following with the treatment of tDCS:
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Change in chemotherapy induced peripheral neuropathy pain score
时间窗: Baseline up to final day of treatment (3 weeks)
The Pain inventory is an assessment of pain level on a 11-point numeric rating scales (0=none to 10=worst).
次要结局
- Change in total opioid requirement (morphine equivalent daily dosage)(Baseline up to 4-6 weeks post-treatment)
- Change in cancer related symptoms(Baseline up to 4-6 weeks post-treatment)
- Change in functioning of Daily Activities(Baseline up to 4-6 weeks post-treatment)
- Change in quality of life questionnaire(Baseline up to 4-6 weeks post-treatment)
- Incidence of adverse events(Up to 4-6 weeks post-treatment)